Explore ›
Finding
Finding
null
Prophylactic dose heparin use during pregnancy in women with Fontan physiology was not significantly associated with increased bleeding risk compared to no antithrombotic therapy (OR 4.68, 95% CI 0.488-44.9, p=0.096).
| Effect size | OR 4.68 |
| CI | 95% CI 0.488 to 44.9 |
| Comparator | No antiplatelet or anticoagulation therapy |
| Effect summary | null; OR 4.68; CI: 95% CI 0.488 to 44.9 |
Connected entities
Interventions
Conditions
Outcomes
Populations
Source
PMC10367127
Bleeding and thrombotic risk in pregnant women with Fontan physiology